Structured evidence table for Elderberry Cold Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Elderberry Cold Randomized Trial | Overall, these findings highlight considerable variability in formulation, disclosure, and health claim practices, underscoring the need for improved transparency and evidence-aligned representation of anthocyanins as bioactive pigments in the Australian nutraceutical market. | 4 | Kumkum R (2026) | Anthocyanin-Rich Pigment Supplements in the Australian Online Market: Sources, Labelling Practices, and Bioactivity Claims. |
| Elderberry Cold Randomized Trial | Amid growing consumer interest in the health benefits of anthocyanins, the market for anthocyanin-based dietary supplements has expanded substantially. | 4 | Kumkum R (2026) | Anthocyanin-Rich Pigment Supplements in the Australian Online Market: Sources, Labelling Practices, and Bioactivity Claims. |
| Elderberry Cold Randomized Trial | However, data on product composition and health claims in the Australian online market remains limited. | 4 | Kumkum R (2026) | Anthocyanin-Rich Pigment Supplements in the Australian Online Market: Sources, Labelling Practices, and Bioactivity Claims. |
| Elderberry Cold Randomized Trial | Although mild upper respiratory tract infections (MURTIs) are typically self-limiting and benign, they can substantially impair a patient's quality of life. | 4 | Smith A (2025) | Holistic care in mild upper respiratory tract infections (MURTIs): an approach to individualized care management. |
| Elderberry Cold Randomized Trial | The wide range of pathogens causing MURTIs often necessitates a symptomatic treatment approach rather than a pathogen-specific treatment. | 4 | Smith A (2025) | Holistic care in mild upper respiratory tract infections (MURTIs): an approach to individualized care management. |
Source documents